1. Abbasi MM, Mehdipour M, Monfaredan A, Jahanban-Esfahlan R (2015) Hesa-A down-regulates erb/b2 oncogene expression and improves outcome of oral carcinoma in a rat model. Asian Pac J Cancer Prev 16(16):6947–6951
2. Ahmadi A (2006) Cytotoxicity and antitumor properties of a marine compound on cancer cells, HESA-A. Cancer Epidemiol Biomark Prevent 15(12 Supplement):B91
3. Ahmadi A, Mohagheghi MA, Fazeli MS, Nahavandian B, Bashardoost N, Jarahi AM, et al (2005) HESA-A: new treatment for breast cancer and choroidal metastasis. Med Sci Monit 11(6):CR300–3
4. Ahmadi A, Naderi G, Asgary S (2005) Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits. Drugs Exp Clin Res 31(1):1–6
5. Ahmadi A, Mohagheghi M, Karimi M, Seyed Ali G, Naseri M (2009) Anticancer effects of HESA-A in patients with metastatic colon cancer. Integr Cancer Ther 8(1):71–74